Implications of the initial Braidwood v. Becerra ruling for colorectal cancer outcomes: a modeling study

Rosita Van Den Puttelaar1, Kewei Sylvia Shi2, Robert Smith3

  • 1Department of Public Health, Erasmus University Medical Center, 3015GD Rotterdam, The Netherlands.

Insights

Reinstating cost-sharing for preventive services could increase colorectal cancer (CRC) screening costs and incidence. A significant drop in screening participation may lead to higher CRC incidence and mortality rates.

Area of Science:

  • Health policy
  • Preventive medicine
  • Cancer epidemiology

Background:

  • The Affordable Care Act (ACA) eliminated patient cost-sharing for services recommended by the United States Preventive Services Task Force (USPSTF).
  • A court ruling (Braidwood Management v. Becerra) threatened to reinstate cost-sharing for USPSTF-recommended services, impacting over 150 million individuals.
  • This ruling specifically targeted colorectal cancer (CRC) screening for ages 45-49 and polyp removal during colonoscopies.

Purpose of the Study:

  • To simulate the potential impact of reinstated cost-sharing on CRC outcomes.
  • To assess the effects of decreased screening participation on CRC incidence and mortality.
  • To analyze the economic implications of changes in screening rates and diagnoses.

Main Methods:

  • Utilized the MISCAN-Colon model for simulation.
  • Incorporated trends in early-onset CRC.
  • Assumed a decline in screening participation rates.

Main Results:

  • An 8-percentage-point decrease in screening participation could lead to a 5.1% increase in CRC incidence and a 9.1% rise in CRC mortality.
  • Slightly lower healthcare costs were projected due to increased patient cost-sharing.
  • Larger reductions in screening participation were associated with increased incidence and delayed diagnoses, potentially raising overall costs.

Conclusions:

  • Reinstating cost-sharing for preventive services, particularly CRC screening, could have significant adverse effects on public health outcomes.
  • Decreased screening participation due to cost barriers may exacerbate the burden of colorectal cancer.
  • Policy decisions regarding cost-sharing for preventive care have substantial implications for cancer incidence, mortality, and healthcare economics.